Nvidia’s AI ambitions in medicine and health care are becoming clear

Nvidia’s AI ambitions in medicine and health care are becoming clear

Nvidia CEO Jensen Huang delivers a keynote address during the Nvidia GTC Conference at the SAP Center in San Jose, California, on March 18, 2024. Justin Sullivan | Getty Images Last week, Nvidia announced deals with Johnson & Johnson for use of generative AI in surgery, and with GE Healthcare to improve medical imaging. The health … Read more

Amgen aims to enter weight loss drug market with a new approach

Amgen aims to enter weight loss drug market with a new approach

The Amgen logo is displayed outside Amgen headquarters on May 17, 2023 in Thousand Oaks, California. Mario Tama | Getty Images Amgen is taking a new approach as it tries to stand out in a crowded field of drugmakers racing to develop the next blockbuster weight loss drug. The biotech company is testing an injectable … Read more

How much people are willing to spend

How much people are willing to spend

Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024.  Hollie Adams | Reuters Demand for weight loss drugs is booming in the U.S. despite their limited insurance coverage and roughly $1,000 monthly price tags before discounts.  But some patients are willing to pay more out of … Read more

Medicare can cover weight loss drugs if used for added health benefit

Medicare can cover weight loss drugs if used for added health benefit

Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024.  Hollie Adams | Reuters Medicare can start covering certain weight loss drugs for the first time – as long as they are approved for an added health benefit, the Centers for Medicare and Medicaid Services said Thursday. … Read more

Wegovy heart health approval won’t mean broad insurance coverage yet

Wegovy heart health approval won’t mean broad insurance coverage yet

Victoria Klesty | Reuters In the U.S., Wegovy is no longer just for weight loss. The blockbuster drug — one of a handful of weight loss treatments to skyrocket in popularity over the last year — is now approved in the U.S. for heart health, too. But that may not translate to wider insurance coverage of … Read more

Wegovy heart health approval won’t mean broad insurance coverage yet

Wegovy heart health approval won’t mean broad insurance coverage yet

Victoria Klesty | Reuters In the U.S., Wegovy is no longer just for weight loss. The blockbuster drug — one of a handful of weight loss treatments to skyrocket in popularity over the last year — is now approved in the U.S. for heart health, too. But that may not translate to wider insurance coverage of … Read more

An overlooked corner of women’s health may be $350 billion market opportunity

An overlooked corner of women’s health may be 0 billion market opportunity

Peathegee Inc | Tetra Images | Getty Images After years of being ignored, menopause has entered the public conversation. Celebrities from Drew Barrymore to Naomi Watts have opened up about symptoms and promoted products. Yet despite the increased chatter, there is a long way to go when it comes to treating symptoms — and a … Read more

WeightWatchers CEO just sent a memo to employees as stock crashes

WeightWatchers CEO just sent a memo to employees as stock crashes

Sima Sistani, CEO, WW International, August 16, 2023. Scott Mlyn | CNBC WeightWatchers CEO Sima Sistani has sent an internal memo to employees attempting to reassure them that the financial position of the company is solid and its new clinical business related to the threat of GLP-1 weight loss drugs is growing faster than expected. … Read more

FDA approves NASH liver disease drug from Madrigal Pharmaceuticals

FDA approves NASH liver disease drug from Madrigal Pharmaceuticals

In this photo illustration, the Madrigal Pharmaceuticals logo is displayed on a smartphone screen.  Rafael Henrique | SOPA Images | Lightrocket | Getty Images The Food and Drug Administration on Thursday approved the first-ever treatment for a common and potentially deadly form of liver disease that affects millions worldwide. The FDA’s decision means Madrigal Pharmaceuticals … Read more

Eli Lilly taps Amazon Pharmacy to help deliver Zepbound, other drugs

Eli Lilly taps Amazon Pharmacy to help deliver Zepbound, other drugs

Close-up of a hand holding a cellphone displaying the Amazon Pharmacy system, Lafayette, California, September 15, 2021.  Smith Collection | Gado | Getty Images Eli Lilly on Wednesday said Amazon Pharmacy will help send certain prescription drugs, including the red-hot weight loss treatment Zepbound, to patients’ homes through the drugmaker’s new direct-to-consumer program.  Starting Wednesday, … Read more